e.g. Filippa Pettersson or Cancer Res. 75(6) , 1102-12, (2015) or 10.1002/anie.201600521
Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1, 2, 4-triazole derivatives as xanthine oxidoreductase inhibitors
In an effort to find a potent xanthine oxidoreductase (XO) inhibitor, we discovered the best compound 2-[2-(2-methoxy-ethoxy)-ethoxy]-5-[5-(2-methyl-pyridin-4-yl)-1H-[1, 2, 4] triazol-3- yl]-benzonitrile 28. Here, we describe the following:(1) the design, synthesis, and structure– activity relationship of a series of 3-phenyl-5-pyridyl-1, 2, 4-triazole derivatives by in vitro studies of XO inhibitory activity in bovine milk and in vivo studies of serum uric acid (UA) ...